Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina Pavlovsky

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current Oncology Reports|February 1, 2018
Chronic Myeloid Leukemia: What Is the Best Strategy to Start and Monitor Treatment Outside Academic Centers?Carolina Pavlovsky, Maria Jose Mela Osorio
Lancet (London, England)|August 23, 2021
Chronic myeloid leukaemiaJorge Cortes, Carolina Pavlovsky, Susanne Saußele
Case Reports in Hematology|August 29, 2012
Planned pregnancy in a chronic myeloid leukemia patient in molecular remissionCarolina Pavlovsky, Isabel Giere, Germán Van Thillo
American Journal of Hematology|March 24, 2009
First-line therapy for chronic myeloid leukemia: Past, present, and futureCarolina Pavlovsky, Hagop Kantarjian, Jorge E Cortes
Seminars in Hematology|July 30, 2023
Inequalities in access to treatment in Argentina: Differences in management of CLL and multiple myeloma?María José Mela Osorio, Carolina Pavlovsky, Miguel Arturo Pavlovsky
Future Oncology (London, England)|September 26, 2018
Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemiaCarolina Pavlovsky, Onyee Chan, Chetasi Talati, et al.
Pharmacotherapy|August 25, 2009
Imatinib mesylate pharmacokinetics before and after sleeve gastrectomy in a morbidly obese patient with chronic myeloid leukemiaCarolina Pavlovsky, Merrill J Egorin, Dhvani D Shah, et al.
Blood Cells, Molecules & Diseases|June 11, 2016
TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcomeNatalia Weich, Cristian Ferri, Beatriz Moiraghi, et al.
Medicina|June 24, 2017
[Chronic myelogenous leukemia: monitoring and predictors of a favorable response to treatment with imatinib]María J Mela Osorio, Isabel A Giere, Isolda Fernández, et al.
Current Hematologic Malignancy Reports|October 16, 2021
Challenges in Chronic Myeloid Leukemia Management in South AmericaKatia B Pagnano, Ana Ines Varela, Carolina Pavlovsky, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Oncology Reports|February 1, 2018
Chronic Myeloid Leukemia: What Is the Best Strategy to Start and Monitor Treatment Outside Academic Centers?Carolina Pavlovsky, Maria Jose Mela Osorio
Lancet (London, England)|August 23, 2021
Chronic myeloid leukaemiaJorge Cortes, Carolina Pavlovsky, Susanne Saußele
Case Reports in Hematology|August 29, 2012
Planned pregnancy in a chronic myeloid leukemia patient in molecular remissionCarolina Pavlovsky, Isabel Giere, Germán Van Thillo
American Journal of Hematology|March 24, 2009
First-line therapy for chronic myeloid leukemia: Past, present, and futureCarolina Pavlovsky, Hagop Kantarjian, Jorge E Cortes
Seminars in Hematology|July 30, 2023
Inequalities in access to treatment in Argentina: Differences in management of CLL and multiple myeloma?María José Mela Osorio, Carolina Pavlovsky, Miguel Arturo Pavlovsky
Future Oncology (London, England)|September 26, 2018
Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemiaCarolina Pavlovsky, Onyee Chan, Chetasi Talati, et al.
Pharmacotherapy|August 25, 2009
Imatinib mesylate pharmacokinetics before and after sleeve gastrectomy in a morbidly obese patient with chronic myeloid leukemiaCarolina Pavlovsky, Merrill J Egorin, Dhvani D Shah, et al.
Blood Cells, Molecules & Diseases|June 11, 2016
TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcomeNatalia Weich, Cristian Ferri, Beatriz Moiraghi, et al.
Medicina|June 24, 2017
[Chronic myelogenous leukemia: monitoring and predictors of a favorable response to treatment with imatinib]María J Mela Osorio, Isabel A Giere, Isolda Fernández, et al.
Current Hematologic Malignancy Reports|October 16, 2021
Challenges in Chronic Myeloid Leukemia Management in South AmericaKatia B Pagnano, Ana Ines Varela, Carolina Pavlovsky, et al.
Pageof 4